Location: Any MSF Office* at the time of hiring; requirement to move to an APH regional hub within 3 years
Travels: Extensive travels up to 40-50%
Duration: MSF Office contract, minimum 4 years commitment, extendable by 3 years, according to MSF practice and subject to national labour laws
Compensation and benefits: MSF practice is to offer the C&B package current in the MSF entity establishing the contract.
Reporting to: MSF International’s Secretary General until 2025 then to the APH Structure Executive Board
Start date: 1st of February 2024
Deadline to apply: 24th November 2023 23:59 CET
*By default, the successful candidate will be offered a contract in the MSF office of their country of residence at the time of application.
Médecins Sans Frontières is searching for a Senior Executive leader of a soon-to-be-born new MSF structure dedicated to the access to products of healthcare. You will decisively contribute to the final steps before its launch and lead a dynamic and ambitious structure expected to contribute directly and strategically to the medico-humanitarian mandate of MSF.
I. MSF INTERNATIONAL
Médecins Sans Frontières (MSF) is an international, independent, medical humanitarian organisation that delivers emergency aid to people affected by armed conflict, epidemics, healthcare exclusion and natural disasters. MSF offers assistance to people based only on need and irrespective of race, religion, gender or political affiliation. MSF International is the legal entity that binds MSF’s 24 sections, 25 associations and other offices together. Based in Geneva, MSF International provides coordination, information and support to the MSF movement, and implements international projects and initiatives as requested.
II. POSITION BACKGROUND
Access to Products for Healthcare (APH) refers to the accessibility, availability, affordability, appropriateness and quality of products for health care for the populations MSF assists and their communities.
Access to Products for Healthcare (APH) is critical to MSF’s Social Mission. MSF has been engaged in a wide variety of ways to improve APH in the past decades. In 2023, MSF’s International General Assembly unanimously voted a Vision that is anchoring addressing Access to Products Healthcare as being integral to its Social Mission: :
“Over the coming decade, MSF will pursue and accentuate its activities aimed at delivering tangible improvements in Access to Products for Healthcare for people who are deprived of them. Whilst our actions will be as specific to operational contexts as possible, they will also be as global as necessary to achieve the specific improvements sought. This work will expose and address problems faced by patients and by operational teams, will involve the mobilization of the entire movement towards common ambitions, and will leverage the potential of partnerships. It will also preserve space for innovation and reflect the multiple expressions of our social mission. These activities will be in-depth, diverse in nature and adequately resourced, and we will learn from their successes and failures. These ambitions will be reflected in how we structure and govern this work.“
Aligned to this Vision, and building on its successes in the past 20 years, MSF is undertaking a steep change in how it organising its work to improve APH to realise its increasing ambitions. The MSF International Board approved the set-up of a new organisational model for MSF’s APH work that will replace the Access Campaign.
The new structure is expected to gradually reach up to 50 positions, including Management Team, and according to the set ambitions. It will be distributed geographically over 3 – 5 regional hubs (still to be identified, according to relevance).
III. PLACE IN THE ORGANISATION
Phase 1(2024): From appointment and until the first APH Structure Strategic Plan is approved by MSF’s International Executive Committee (ExCom), the APH Structure Executive Director (hereafter the executive Director) will report to the Secretary General and be a member of the APH Model organisational change committee (OMC).
Phase 2(from 2025): After approval of the APH Structure Strategic Plan, the Executive Director will be accountable to the APH Structure Executive Board for the proper oversight and management of the APH Structure resources and the execution of the APH Structure mandate.
IV. PURPOSE OF THE POSITION
Phase 1 (2024): To contribute to and lead the finalisation of key elements of the APH Model and their initial set-up with a focus on the APH Structure and its Strategic Plan.
Phase 2 (from 2025): To finalise the set-up of the APH Structure and lead the execution of its Strategic Plan.
V. MAIN RESPONSIBILITIES
Phase 1: The Executive Director:
• Is a member of and participates to the OMC which defines specific tasks in relation to the implementation of the change plan. In particular, the Executive Director participates to the oversight of the Humanitarian Representation Team review
• Appoints and manages the APH Structure Management Team members and any other APH Structure staff planned to operate post APH Strategic Plan approval.
• Leads the development of the first APH Structure Strategic plan
• Leads the development of the APH Structure approval, planning and administrative policies and processes
• In particular, the ED is responsible for ensuring that the APH Structure:
• Leads the development of the APH Structure internal planning and administrative policies and processes
• Leads the development and implementation of the APH Structure Strategic plans
• Translate the APH Strategic Plans into individual projects and Initiatives within annual plans and budgets validated by the APH Structure Executive Board:
• Is a member of, and participates to the MedOp (Platform for medical directors and directors of operations)